Aidong Wen

8.0k total citations
261 papers, 6.3k citations indexed

About

Aidong Wen is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Aidong Wen has authored 261 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 51 papers in Pharmacology and 43 papers in Complementary and alternative medicine. Recurrent topics in Aidong Wen's work include Traditional Chinese Medicine Analysis (34 papers), Natural product bioactivities and synthesis (26 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Aidong Wen is often cited by papers focused on Traditional Chinese Medicine Analysis (34 papers), Natural product bioactivities and synthesis (26 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Aidong Wen collaborates with scholars based in China, South Korea and United States. Aidong Wen's co-authors include Yi Ding, Chao Guo, Yuwen Li, Jialin Duan, Wei Guo, Yanrong Zhu, Yanyan Jia, Miaomiao Xi, Jingwen Wang and Tianlong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Aidong Wen

250 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aidong Wen China 43 2.8k 1.0k 903 797 720 261 6.3k
Guibo Sun China 51 3.6k 1.3× 964 1.0× 619 0.7× 557 0.7× 793 1.1× 211 6.7k
Joen‐Rong Sheu Taiwan 43 2.1k 0.7× 846 0.8× 1.0k 1.1× 534 0.7× 624 0.9× 233 6.0k
Xiaobo Sun China 42 3.1k 1.1× 696 0.7× 497 0.6× 653 0.8× 612 0.8× 178 5.5k
Jae‐Young Um South Korea 45 3.5k 1.2× 867 0.9× 759 0.8× 824 1.0× 842 1.2× 263 7.5k
Gholamreza Karimi Iran 51 3.0k 1.1× 744 0.7× 928 1.0× 1.3k 1.6× 886 1.2× 294 8.5k
Junping Kou China 40 2.9k 1.0× 651 0.6× 444 0.5× 460 0.6× 551 0.8× 175 5.2k
Zhenzhong Wang China 39 2.9k 1.0× 1.1k 1.1× 723 0.8× 1.3k 1.6× 1.1k 1.5× 390 6.2k
Ziren Su China 51 3.5k 1.2× 767 0.8× 1.3k 1.5× 1.0k 1.3× 1.7k 2.3× 251 7.6k
Ki Churl Chang South Korea 47 3.0k 1.1× 513 0.5× 814 0.9× 492 0.6× 709 1.0× 169 6.5k
Jinyong Peng China 56 4.6k 1.6× 721 0.7× 732 0.8× 1.1k 1.4× 1.4k 2.0× 220 9.3k

Countries citing papers authored by Aidong Wen

Since Specialization
Citations

This map shows the geographic impact of Aidong Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidong Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidong Wen more than expected).

Fields of papers citing papers by Aidong Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aidong Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidong Wen. The network helps show where Aidong Wen may publish in the future.

Co-authorship network of co-authors of Aidong Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Aidong Wen. A scholar is included among the top collaborators of Aidong Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aidong Wen. Aidong Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jin, Chao Guo, Jia Ju, et al.. (2025). Formononetin mitigates alcoholic liver disease by restoring ALDH2 function and inducing ERK1/2–Nrf2 antioxidant signaling. Phytomedicine. 148. 157408–157408.
2.
Long, Pan, Tao Chen, Kaifeng Li, et al.. (2021). ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes‐Induced Retinopathy through Depressing Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2021(1). 1641717–1641717. 18 indexed citations
3.
Liu, Tianlong, Wenjun Wang, Ning Su, et al.. (2019). Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats. Rejuvenation Research. 22(6). 503–512. 11 indexed citations
4.
Liu, Tianlong, Minna Liu, Tiejun Zhang, et al.. (2018). Z‐Guggulsterone attenuates astrocytes‐mediated neuroinflammation after ischemia by inhibiting toll‐like receptor 4 pathway. Journal of Neurochemistry. 147(6). 803–815. 31 indexed citations
5.
Wen, Aidong, et al.. (2017). Determination of phloroglucinol by HPLC-MS/MS and its application to a bioequivalence study in healthy volunteers.. PubMed. 21(8). 1990–1998. 5 indexed citations
6.
Mu, Fei, Jialin Duan, Lin Rui, et al.. (2016). Metabolomic study on preventive effect of Aqueous extract and Volatile oil of Dalbergia Odorifera on myocardial ischemia/reperfusion injury in rats. 32(10). 1382. 1 indexed citations
7.
Chen, Suning, Xingmei Zhu, Hongyu Qiao, et al.. (2015). Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumor Biology. 37(2). 2321–2331. 36 indexed citations
8.
Ding, Yi, Minchun Chen, Min Wang, et al.. (2014). Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway. Scientific Reports. 4(1). 7002–7002. 142 indexed citations
9.
Wen, Aidong. (2013). Bioequivalence of two kinds of imatinib preparations in healthy volunteers. Chinese Journal of New Drugs and Clinical Remedies.
10.
Wen, Aidong. (2012). Protective effect of sodium Danshensu on myocardial ischemia-reperfusion injury via inhibiting inflammatory response. Central South Pharmacy. 1 indexed citations
11.
Wen, Aidong. (2012). Pharmacokinetics of levetiracetam tablets in healthy volunteers. The Chinese Journal of Clinical Pharmacology. 2 indexed citations
12.
Wen, Aidong. (2011). Determination of Ivabradine in Human Plasma by LC-MS/MS and Study of Pharmacokinetics. Xiandai shengwu yixue jinzhan. 2 indexed citations
13.
Qiao, Yi, Jie Peng, Yanyan Jia, et al.. (2011). Pharmacokinetics of metolazone tablet determined by LC-MS/MS in healthy volunteers. Zhongguo xin yao zazhi. 20(24). 2446–2449. 1 indexed citations
14.
Wen, Aidong & Wei Sun. (2011). Tolerance and Safety Study of Aerosol Inhalation of Recombinant Human Interferon α1b in Children with Viral Pneumonia. Zhongguo yaofang. 1 indexed citations
15.
Wen, Aidong. (2010). Effect of Decocting Safflower and Angelica Alone or Combined on Content Variation of Active Ingredient. Zhōnghuá yàoxué zázhì. 1 indexed citations
16.
Wen, Aidong. (2010). Pharmacokinetic character of safflor yellow extraction and hydroxysafflor yellow A in blood stasis rats. 1 indexed citations
17.
Wen, Aidong, et al.. (2009). Pharmacodynamics and Pharmacokinetics of Hydroxy Safflor Yellow A in Healthy Volunteers. Zhongguo yaofang. 2 indexed citations
18.
Wen, Aidong. (2007). Bioequivalence of compound gossypol acetic acid tablets in healthy Chinese female volunteers. Zhongguo xin yao zazhi.
19.
Wen, Aidong, et al.. (2003). Therapeutic Effect of Ornidazole on the Anaerobic Infections After Maxillofacial Plastic Surgery. Zhongguo yaofang. 1 indexed citations
20.
Huang, Xi, et al.. (1995). Is it possible to study the pharmacokinetics of chemical component of herbal recipe?. Chinese Journal of Integrated Traditional and Western Medicine. 1(4). 297–300. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026